Ann Clin Microbiol 2024;27(3):185-196. Seasonality and epidemiological trends in species distribution and antifungal susceptibility of Candida species isolated from various clinical specimens conducted during 2011–2022, Korea: a retrospective surveillance study

Table 3. Yearly comparison analysis showing the epidemiological trend of Candida infection between 2012 and 2022
Candida infection 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2012-2022
Candida spp. 465 401 414 615 794 550 802 954 1,282 1,092 1,164 8,533
  (0.84) (0.66) (0.67) (0.95) (1.20) (0.94) (1.13) (1.36) (2.15) (1.71) (1.77) (1.22)
Candida albicans 216 216 207 267 403 243 387 519 577 503 540 4,078
  (46.45) (53.87) (50.00) (43.41) (50.76) (44.18) (48.25) (54.40) (45.01) (46.06) (46.39) (47.79)
NAC 249 185 207 348 391 307 415 435 705 589 624 4,455
  (53.55) (46.13) (50.00) (56.59) (49.24) (55.82) (51.75) (45.60) (54.99) (53.94) (53.61) (52.21)
C. tropicalis 41 61 94 139 198 191 244 207 294 251 248 1,968
  (8.82) (15.21) (22.71) (22.60) (24.94) (34.73) (30.42) (21.70) (22.93) (22.99) (21.31) (23.06)
C. glabrata 94 34 34 135 118 66 73 143 272 210 226 1,405
  (20.22) (8.48) (8.21) (21.95) (14.86) (12.00) (9.10) (14.99) (21.22) (19.23) (19.42) (16.47)
C. parapsilosis 23 23 21 44 38 17 69 45 88 74 99 541
  (4.95) (5.74) (5.07) (7.15) (4.79) (3.09) (8.60) (4.72) (6.86) (6.78) (8.51) (6.34)
Total 55,448 60,344 61,735 64,943 66,428 58,371 71,027 69,998 59,669 63,762 65,685 697,410

Values are presented as n (%) or n.
In 2019, of the 954 positive cases for Candida, C. albicans and NAC accounted for 54.4 % (519 cases) and 45.6 % (435 cases) , respectively. C. albicans was identified significantly more frequently (p < 0.05). In 2020, this trend was reversed and significantly more NACs were identified. This trend is expected to continue after the year 2020.
Abbreviation: NAC, non-albicans Candida.